https://finance.yahoo.com/news/chroma-medicine-presents-preclinical-vivo-150000625.html
0
0
Chroma Medicine Presents Preclinical In Vivo Data Showing Durable Cholesterol Reduction with a PCSK9-Targeted Epigenetic Editor at the 2023 AHA Scientific Sessions - Yahoo Finance
11/11/23 at 3:00pm
Organization
Yahoo Entertainment
Author
PR Newswire
Details
44 words
Summarize
Science Health Chroma Medicine Presents Preclinical In Vivo Data Epigenetic Editor PCSK9 editing therapeutics AHA Scientific Sessions - Yahoo Finance Chroma Medicine, Inc. genomic medicine company
Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented new preclinical data...
Create an account or login to join the discussion